Kansas took its 7-hydroxymitragynine restriction in July 2026, one of four states to act that month after Florida opened the wave in June. This post explains what the action covers, where it sits in the 2025–2026 timeline, and what Kansas buyers should know. Standing caveats: general information, not legal advice; check the current law for your situation; the full picture is in the 2026 legal status guide.
What the July 2026 action did
- 7-OH products restricted. Kansas’s action targeted 7-hydroxymitragynine products — the concentrated tablet and extract category — rather than kratom leaf broadly, in the same compound-specific pattern as Florida’s June action. This is a 7-OH restriction, not a general kratom ban.
- Part of the July wave. Virginia, Tennessee, and North Dakota took parallel 7-OH actions in the same month, completing a pattern within weeks of Florida. The state-by-state detail is in the overview map.
- The timeline context. Louisiana’s kratom ban (August 2025) came first; Massachusetts’s emergency order (August 2026) came last; the June–July 2026 cluster sits in the middle. Fourteen months, seven state actions — the pace is the story.
Why the July wave happened when it did
The state actions tracked the federal movement in real time:
- The DEA s alkaloid scheduling. Mitragynine pseudoindoxyl, MGM-15, and MGM-16 moved to temporary Schedule I effective August 26, 2026 — landing just weeks after the July wave, which makes the sequencing clear: the states moved first, and the federal action on related alkaloids confirmed the direction. The DEA 2026 update has the full timeline.
- The pending 7-OH threshold rule. The federal action on 7-OH products above a potency level was already announced and pending (notice July 6, 2026), which put a dated deadline on the category’s gray zone. State regulators do not wait for federal certainty when the direction is legible.
- Concentration as the trigger. 7-OH products are the highest-concentration kratom-alkaloid products on the market, and the regulators treated that concentration as the defining risk characteristic. The category’s potency structure is in what strength means.
What it means in practice
- We do not ship 7-OH products to Kansas addresses, consistent with our policy of not selling restricted products into restricted states. The shipping guide lists the current restricted-state list.
- No workarounds. A cross-state purchase, a routed package, or a personal bring-in does not change the exposure of possessing a restricted product in Kansas. Any content suggesting otherwise is selling you something you should not have.
- If you hold pre-restriction product, a lawyer is the source. Do not resell or transfer restricted product; keep your order records and batch documentation (the batch verification habit applies to records too); and let a licensed attorney give you the position for your specific facts.
- Buyers elsewhere: the map is still moving. If your state is not on the restricted list today — Virginia, Tennessee, Kansas, Florida, North Dakota (7-OH); Louisiana (kratom); Massachusetts (emergency order) — the current check is the habit. The overview map is that read.
Bottom line
Kansas restricted 7-OH products in July 2026, one of the month’s four-state wave. For Kansas buyers the answer is a hard no: no shipping, no workarounds, and a lawyer for pre-restriction product questions. For everyone else, Kansas is a data point — the restricted list keeps growing, the federal threshold rule is pending, and the FAQ center carries the standing shipping questions. The shop serves permitted addresses only, with 21+ verification.